Sort by
Refine Your Search
-
. This project is funded by the European Space Agency (ESA) and is and is fixed-term for 24 months. The project “TMNT – Threat Monitoring Networked Team” will develop multi-robot scouting approaches to explore and
-
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme focused on understanding and preventing disease progression in myeloproliferative neoplasms (MPNs). The role would suit an ambitious, proactive and detail-oriented individual,...
-
undertake high-impact research at the interface of materials science, advanced imaging, and artificial intelligence, with a particular focus on developing automated approaches for analysing multi-modal
-
possible start date, based on the end date of the grant, is 09/10/2027. The successful candidates will be members of the Infectious Disease Modelling research group (https://www.maths.ox.ac.uk/groups
-
) Further information can be found at http://www.eng.ox.ac.uk/jobs/home Only online applications received before midday on 8 May 2026 can be considered. You will be required to upload a covering letter
-
Philanthropy and is fixed-term until 31 Dec 2027. A further extension to this would be based on funding availability. You will conduct hands-on empirical research in multi-agent security and agentic AI security
-
Marie Skłodowska-Curie Action (MSCA) Doctoral Network Early-Stage Researcher (ESR) to work on “Active exploration of iridescence and gloss”. We are seeking an Early-Stage Researcher (ESR) to work
-
Kennedy Institute is a biomedical research centre uniquely bringing together discovery science and early-stage clinical research, to develop transformative new therapies for chronic inflammatory and
-
the lunar farside. The successful candidate will contribute to the development and scientific programme of the Lunar Farside Technosignature and Transients Telescope (LFT3; https://lft3.space). Lunar Farside
-
therapeutic advancement for ALS is the capacity to deliver Phase 3 randomised controlled trials at pace for a growing pool of drugs. Through multiple cohort studies, blood neurofilament light chain (NfL) level